BWX Technologies
BWXT
$161.54
+6.07%
BWX Technologies, Inc. is a specialty manufacturer and service provider of nuclear components, operating in two primary segments: Government Operations, which produces naval nuclear reactors and fuel for the U.S. Naval Nuclear Propulsion Program, and Commercial Operations, which designs and manufactures commercial nuclear steam generators, heat exchangers, pressure vessels, and spent fuel storage containers. As a dominant player in the nuclear supply chain, BWXT holds a unique competitive position as the sole manufacturer of large naval nuclear reactors in North America, with a significant backlog that grew 50% in 2025, underscoring its strategic importance in both defense and the resurgent commercial nuclear sector. The current investor narrative centers on the company's robust multi-year revenue visibility from government contracts and expanding commercial nuclear opportunities, yet the stock has faced significant selling pressure in 2026, declining over 25% from its 52-week high, as investors weigh near-term execution risks from recent acquisitions and broader market volatility against long-term growth potential.…
BWXT
BWX Technologies
$161.54
Related headlines
Investment Opinion: Should I buy BWXT Today?
We rate BWXT a Hold, as the stock offers a unique long-term growth opportunity but is currently facing significant near-term headwinds. The analyst consensus is Buy with an average target of $234.45, implying 53.4% upside, but the stock's technical downtrend and premium valuation warrant caution. The thesis is that BWXT's dominant position in nuclear components and 50% backlog growth justify a premium, but the market is currently pricing in execution risks and broader volatility.
Sign up to view all
BWXT 12-Month Price Forecast
The AI assessment is neutral, reflecting a balance between strong fundamentals and challenging technicals. The company's growth and backlog are impressive, but the valuation is rich, and the stock is in a downtrend. A shift to bullish would require a sustained price recovery above $170 and confirmation of margin stability, while a bearish stance would be triggered by a break below $147.74 or a significant earnings miss.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on BWX Technologies's 12-month outlook, with a consensus price target around $232.31 and implied upside of +43.8% versus the current price.
Average Target
$232.31
0 analysts
Implied Upside
+43.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$170 - $290
Analyst target range
The target price range spans from a low of $190.00 to a high of $290.00, with the low target still 24.3% above the current price, reflecting a floor of expected value, while the high target implies a 89.7% upside, likely assuming accelerated growth in commercial nuclear and continued government spending. The wide spread of $100 between low and high targets indicates high uncertainty about the pace of nuclear adoption and execution risks. Recent institutional actions show a positive shift, with Seaport Global upgrading from Neutral to Buy in June 2026 and Deutsche Bank from Hold to Buy in May 2026, while Truist has maintained a Hold, suggesting a mixed but improving sentiment. The consensus implies strong conviction in BWXT's long-term prospects, but the wide range highlights the volatility and risk inherent in the nuclear sector.
Bulls vs Bears: BWXT Investment Factors
BWXT presents a compelling long-term growth story driven by its monopoly in naval nuclear reactors and a 50% backlog increase, but the stock faces near-term headwinds from a premium valuation and a sharp downtrend. The bull case is supported by strong revenue growth, analyst upgrades, and a wide moat, while the bear case centers on valuation risk, high debt, and execution concerns. Currently, the bearish technical momentum and valuation premium outweigh the bullish fundamentals, making the stock a high-risk, high-reward opportunity. The most critical tension is whether the market will re-rate the stock higher based on its growth potential or continue to punish the premium multiple amid broader market volatility.
Bullish
- Dominant Naval Nuclear Monopoly: BWXT is the sole manufacturer of large naval nuclear reactors in North America, a position that provides an unmatched competitive moat and recurring revenue from the U.S. Naval Nuclear Propulsion Program. This monopoly underpins the company's strategic importance and long-term contract visibility.
- 50% Backlog Growth in 2025: The company reported a 50% increase in backlog during 2025, signaling robust multi-year revenue visibility. This growth, highlighted in the February 2026 earnings release, supports the sustainability of the 26.2% YoY revenue growth seen in Q1 2026.
- Accelerating Revenue Growth: Q1 2026 revenue grew 26.2% YoY to $861.1 million, up from $682.3 million in Q1 2025, with consistent growth over the past five quarters. This acceleration, driven by both government and commercial segments, demonstrates strong demand for nuclear components.
- Analyst Upgrades and High Targets: Seaport Global upgraded to Buy in June 2026 and Deutsche Bank to Buy in May 2026, reflecting improving sentiment. The average analyst target of $234.45 implies 53.4% upside from the current price of $152.85, with a high target of $290 suggesting 89.7% upside.
Bearish
- Premium Valuation Leaves No Room for Error: The trailing PE of 48.0x and forward PE of 29.1x are significantly above the broader market and historical averages. The PEG ratio of 2.84 suggests the stock is expensive relative to its growth rate, leaving little margin for disappointment.
- Sharp Downtrend and Weak Relative Strength: The stock is down 25.8% over the past six months and 7.8% over the past year, with relative strength of -37.9% vs. the S&P 500 over six months. The price sits just 3.3% above the 52-week low of $147.74, indicating persistent selling pressure.
- High Debt-to-Equity Ratio: Debt-to-equity stands at 1.64, indicating significant leverage. While manageable given stable cash flows, this increases financial risk, especially if interest rates remain elevated or if acquisitions require additional debt.
- Execution Risks from Acquisitions: Recent acquisition news in April 2026 caused the stock to slide, highlighting market concerns about integration and near-term execution. The company's expansion into commercial nuclear may face delays or cost overruns, impacting margins.
BWXT Technical Analysis
BWXT is in a pronounced downtrend, with the stock price at $152.85 as of August 28, 2026, down 7.83% over the past year and 25.79% over the past six months. The current price sits at 63.2% of its 52-week range (between $147.74 low and $241.82 high), indicating the stock is trading near the lower end of its yearly range, which often signals either a value opportunity or a falling knife, depending on fundamental support. The 52-week low of $147.74 is just 3.3% below the current price, suggesting the stock is testing critical support levels, while the high of $241.82 represents a significant resistance point that would require a 58.2% rally to reclaim.
Beta
0.76
0.76x market volatility
Max Drawdown
-37.3%
Largest decline past year
52-Week Range
$148-$242
Price range past year
Annual Return
-0.3%
Cumulative gain past year
| Period | BWXT Return | S&P 500 |
|---|---|---|
| 1m | -4.2% | +2.0% |
| 3m | -12.5% | +1.0% |
| 6m | -17.4% | +11.8% |
| 1y | -0.3% | +18.1% |
| ytd | -11.2% | +11.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BWXT Fundamental Analysis
BWXT's revenue trajectory is robust, with Q1 2026 revenue of $861.1 million, up 26.2% year-over-year from $682.3 million in Q1 2025, and the company has consistently grown revenue over the past five quarters, from $671.9 million in Q3 2024 to $885.8 million in Q4 2025. The growth is driven by both segments, with Government Operations contributing $577.9 million and Commercial Operations $283.6 million in the latest quarter, reflecting strong demand in naval nuclear and commercial nuclear components. This accelerating growth, coupled with a 50% backlog increase in 2025, provides strong multi-year revenue visibility, supporting the investment case for long-term expansion.
Quarterly Revenue
$861095000.0B
2026-03
Revenue YoY Growth
+26.2%
YoY Comparison
Gross Margin
23.0%
Latest Quarter
Free Cash Flow
$328104000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BWXT Overvalued?
Given BWXT's positive net income, the PE ratio is the primary valuation metric. The trailing PE is 48.01x, while the forward PE is 29.09x, indicating the market expects significant earnings growth, with the forward multiple implying a 39.1% earnings increase over the next year. This gap between trailing and forward PE suggests investors are pricing in robust growth, which is supported by the company's 26.2% revenue growth and expanding backlog, but it also leaves little room for disappointment.
PE
48.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 9x~52x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
31.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are elevated due to BWXT's high debt-to-equity ratio of 1.64, which increases interest expense and financial fragility. While the company generates positive free cash flow of $328 million, its net margin of 10.3% is modest, and any cost overruns on fixed-price government contracts could compress margins further. The current ratio of 2.32 provides some liquidity cushion, but the reliance on government contracts creates revenue concentration risk, as a single program delay could impact results. Additionally, the payout ratio of 28% and dividend yield of 0.58% indicate limited income support, making the stock more dependent on capital appreciation.
FAQ
The key risks include: 1) Financial risk from high debt-to-equity of 1.64, which could strain cash flows if interest rates rise. 2) Market risk from a premium valuation that could compress if growth disappoints. 3) Competitive risk from new entrants in commercial nuclear, though the naval monopoly is protected. 4) Company-specific risk from acquisition integration and execution. The most severe risk is a prolonged downturn in government defense spending, which could impact the majority of revenue.
The 12-month forecast is mixed, with a base case probability of 50% for a price range of $190-$220, a bull case probability of 25% for $220-$290, and a bear case probability of 25% for $147-$170. The most likely scenario is the base case, assuming continued revenue growth and stable margins. The stock is expected to recover from its current downtrend, but the pace depends on execution and market sentiment. Analysts are generally bullish, with an average target of $234.45.
BWXT is trading at a trailing PE of 48.0x and forward PE of 29.1x, which is a premium to the broader market and its own historical average. The PEG ratio of 2.84 suggests the stock is overvalued relative to its growth rate. However, the company's monopoly position and 50% backlog growth justify a premium. The market is pricing in strong future earnings growth, as evidenced by the 39.1% expected EPS increase. Compared to peers, BWXT's valuation is at a premium, but the unique nature of its business may warrant it.
BWXT offers a compelling long-term growth story, but the current risk/reward is balanced. With an average analyst target of $234.45, the stock has 53.4% upside, but the premium valuation (forward PE of 29.1x) and technical downtrend introduce significant risk. It could be a good buy for investors with a 3-5 year horizon who believe in the nuclear renaissance, but it is not suitable for short-term traders or those seeking income. The stock is near its 52-week low, providing a potential entry point, but a break below $147.74 would signal further downside.
BWXT is better suited for long-term investment due to its multi-year backlog and structural growth drivers in nuclear energy. The stock has a beta of 0.76, indicating lower volatility than the market, but it has been in a downtrend recently. Short-term trading is risky given the technical weakness and valuation concerns. A minimum holding period of 3-5 years is recommended to allow the backlog to convert into earnings and for the commercial nuclear market to develop. The dividend yield is low at 0.58%, so total return will depend on capital appreciation.